Advertisement

Drug Therapy for Complex Partial Seizures

  • Joseph Bruni
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 497)

Abstract

Optimal medical management of the patient with complex partial seizures should take into account a number of factors, including the efficacy of a drug, its adverse effects profile, its pharmacokinetics, its ease of use, the potential for drug interactions, the age and sex of the patient, emergency use and cost. Only recently have data from controlled clinical trials become available comparing the relative efficacy and adverse effects of the standard antiepileptic drugs. It has become apparent that, because of a lack of significant differences in efficacy, other considerations play an important role in the choice of a specific antiepileptic drug.

Keywords

Antiepileptic Drug Adjunctive Therapy Partial Seizure Seizure Frequency Sodium Valproate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    L Anhut, H., Ashman, R, Feuerstein, T.J., Sauermann, W, Saunders, M., and Schmidt, B. Gabapentin as add-on therapy in patients with partial seizures: A double-blind placebo-controlled studyEpilepsia35 (1994) 795–801.CrossRefGoogle Scholar
  2. 2.
    Biton, V., Montouris, G.D., Ritter, F., Riviello, J.J., Reife, R., Lim, P., and Pledger, G. A randomized placebo-controlled study of topiramate in primary generalized tonic clonic seizuresNeurology53 (1999) 1330–1337.CrossRefGoogle Scholar
  3. 3.
    Brodie, M.J., Richens, A., Yuen, A.W.C., and the UK Lamotrigine/Carbamazepine Monotherapy Trial Group. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsyLancet,345 (1995) 476–479.CrossRefGoogle Scholar
  4. 4.
    Browne, T.R., Mattson, R.H., and Penry, J.K. Multicenter long-term safety and efficacy study of vigabatrin for refractory complex partial seizures: An updateNeurology41 (1991) 363–364.PubMedCrossRefGoogle Scholar
  5. 5.
    Bruni, J. Efficacy of topiramateCan. J. Neurot Sci.25 (1998) 56–57.Google Scholar
  6. 6.
    Bruni, J. Outcome evaluation of gabapentin as add-on therapy for partial seizuresCan. J. Neurol. Sci.25 (1998) 134–140.PubMedGoogle Scholar
  7. 7.
    Callaghan, N., Kenny, R.A., O’Neill, B., Crowley, M., and Gogginl T. A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsyJ. Neurol. Neurosurg. Psychiatry48 (1985) 639–644.PubMedCrossRefGoogle Scholar
  8. 8.
    Dean, C. and Penry, J.K. Carbamazepine valproate therapy in 100 patients with partial seizures failing carbamazepine monotherapy: Long term follow upEpilepsia29 (1988) 687.CrossRefGoogle Scholar
  9. 9.
    Dulac, O. The use of lamotrigine in childrenRev. Contemp. Pharmacother.5 (1994) 133–139.Google Scholar
  10. 10.
    Elterman, R.D., Glauser, T.A., Wyllie, E., Reife, R., Wu, S.C., and Pledger, G. A double-blind, randomized trial of topiramate as adjunctive therapy for Daihol-onset seizures in childrenNeurology52 (1998) 1338–1334.CrossRefGoogle Scholar
  11. 11.
    Faught, E., Sachdeo, R., Remler, M., Chayasirisobhon, S., Iragui-Madoz, V.J., Ramsay, R.E., Sutula, T.P., Kanner, A., Harner, R.N., Kuzniecky, R., Kramer, L.D., Kamin, M., and Rosenberg, A. Felbamate monotherapy for partial onset seizures: An active control studyNeurology43 (1993) 688–692.PubMedCrossRefGoogle Scholar
  12. 12.
    Gram, L., Klosterskov, P., and Dam, M. Gamma-vinyl GABA: A double-blind placebo controlled trial in partial epilepsyAnn. Neurol.17 (1985) 262–266.PubMedCrossRefGoogle Scholar
  13. 13.
    Guberman, A., Bruni, J., Deforges, C., Jones, M., Lee, M.A., McLaughlan, R., Ogunyemi, A., Pillay, N., Purves, S., Sadler, M., Starreveld, E., Sussman, N., Vachon, L., and Weaver, D. Vigabatrin in uncontrolled complex partial seizures in adult patients with epilepsy: A double-blind, placebo-controlled, dose-ranging studyCan. J. Neurol. Sci.21 (1994) Suppl. 2: S17–S18.Google Scholar
  14. 14.
    Heller, A.J., Chesterman, E, Elwes, R.D.C., Crawford, P., Chadwick, D., Johnson, A.L., and Reynolds, E.H. Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for new diagnosed adult epilepsy: A randomized comparative monotherapy trial, J.Neurol. Neurosurg. Psychiatry58 (1995) 44–50.PubMedCrossRefGoogle Scholar
  15. 15.
    Kalviainen, R., Aikia, M., Saukkonen, A.M., Mervaala, E., and Riekkinen, P.J. Sr. Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsyArch. Neurol.52 (1995) 989996.CrossRefGoogle Scholar
  16. 16.
    Kosteljanetz, M., Christiansen, J., Dam, A.M., Hansen, B.S., Lyon, B.B., Pedersen, H., and Dam, M. A controlled clinical trial in focal motor and generalized epilepsyArch. Neurol.36 (1979) 22–24.PubMedCrossRefGoogle Scholar
  17. 17.
    Leach, J.P. and Brodie, M.J. Lamotrigine: Clinical use. In: R.H. Levy, R.N. Mattson, and B.S. Meldrum (Eds.)Antiepileptic DrugsRaven Press (1995) 889–895.Google Scholar
  18. 18.
    Marson, A.G., Kadir, Z.A., and Chadwick, D.W. New antiepileptic drugs: a systematic review of their efficacy and tolerabilityBMJ313 (1996) 1169–1174.PubMedCrossRefGoogle Scholar
  19. 19.
    Mattson, R.H., Cramer, J.A., Collins, J.F., Smith, D.B., Delgado-Escueta, A.V., Browne, T.R., Williamson, ED., Treiman, D.M., McNamara, J.O., McCutchen, C.B., Homan R.W., Crill, W.E., Lubozynski, M.F., Rosenthal, N.P, and Mayersdorf, A. Comparison of carbamazepine, phenobarbital, phenytoin and primidone in partial and secondarily generalized tonic-clonic seizuresN. Engl. J. Med.313 (1985) 145–151.PubMedCrossRefGoogle Scholar
  20. 20.
    Mattson, R.H., Cramer, J.A., and Collins, J.F. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adultsN. Engl. J Med.327 (1992) 765–771.PubMedCrossRefGoogle Scholar
  21. 21.
    Panayiotopoulos, C.P., Ferrie, C.D., Knott, C., and Robinson, R.O. Interaction of lamotrigine with sodium valproateLancet341 (1993) 445.PubMedCrossRefGoogle Scholar
  22. 22.
    Plaa, G.L. and Willmore, L.J. General Principles: Toxicology. In: R.H. Levy, R.H. Mattson, and B.S. Meldrum (Eds.)Antiepileptic DrugsRaven Press (1995) pp. 51–60.Google Scholar
  23. 23.
    Ramsay, R.E., Wilder, B.J., Berger, J.R., and Bruni, J. A double-blind study comparing carbamazepine with phenytoin as initial seizure therapy in adultsNeurology33 (1983) 904–910.PubMedCrossRefGoogle Scholar
  24. 24.
    Reynolds, E.H., Ring, H.A., Farr, I.N., Heller, A.J., and Elwes, R.D. Open double-blind and long term study of vigabatrin in chronic epilepsyEpilepsia32 (1991) 530–538.PubMedCrossRefGoogle Scholar
  25. 25.
    Rimmer, E.M. and Richens, A. Double-blind study of gamma-vinyl GABA in patients with refractory epilepsyLancet1 (1984) 189–190.PubMedCrossRefGoogle Scholar
  26. 26.
    Rodin, E., Rim, C.S., Kitano, H., Lewis, R., and Rennick, P.M. A comparison of the effectiveness of primidone versus carbamazepine in epileptic patientsJ. Nerv. Ment. Dis.163 (1976) 41–46.PubMedCrossRefGoogle Scholar
  27. 27.
    Rosa, F.W. Spina bifida in infants of women treated with carbamazepine during pregnancyN Engl. J. Med.324 (1991) 674–677.PubMedCrossRefGoogle Scholar
  28. 28.
    Sachdeo, R., Kramer, L.D., et al. Felbamate monotherapy: Controlled trial in patients with partial onset seizuresAnnals of Neurology32 (1992) 386–392.PubMedCrossRefGoogle Scholar
  29. 29.
    Schneiderman, J.H. Topiramate: Pharmacokinetics and pharmacodynamicsCan. J Neurol. Sci.25 (1998) 53–55.Google Scholar
  30. 30.
    Shorvon, S.D. Benzodiazepines: Clobazam. In: R.H. Levy, R.H. Mattson, and B.S. Meldrum (Eds.)Antiepileptic DrugsRaven Press (1995) pp. 763–777.Google Scholar
  31. 31.
    Sivenius, J., Ylinen, A., Murros, K., Mumford, J.P, and Riekkinen, P.J. Vigabatrin in drug resistant partial epilepsy: A 5 year follow-up studyNeurology41 (1991) 562–565.PubMedCrossRefGoogle Scholar
  32. 32.
    Steiner, T.J., Dellaportas, C.I., Findley, L.J., Gross, M., Gibberd, F.B., Perkin, G.D., Park, D.M., and Abbott, R. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoinEpilepsia40 (1999) 601–607.PubMedCrossRefGoogle Scholar
  33. 33.
    Tassinari, C.A., Michelucci, R., Ambrosetto, G., and Salvi, F. Double blind study of vigabatrin in the treatment of drug resistant epilepsyArch. Neurol.44 (1987) 688–692.CrossRefGoogle Scholar
  34. 34.
    Turnbull, D.M., Howel, D., Rawlins, M.D., and Chadwick, D.W. Which drug for the adult epileptic patient: Phenytoin or valproate?Lancet290 (1985) 815–819.Google Scholar
  35. 35.
    UK Gabapentin Study Group. Gabapentin in partial epilepsyLancetI (1990) 1114–1117.Google Scholar
  36. 36.
    US Gabapentin Study Group. Gabapentin as add-on therapy in refractory epilepsy: A double-blind, placebo-controlled, parallel-group studyNeurology43 (1993) 2292–2298.CrossRefGoogle Scholar
  37. 37.
    Valproic acid and spina bifida. Preliminary reports, M.M. W.R., 31 (1982) 565–566.Google Scholar
  38. 38.
    Wilder, B.J. (Ed.) Rational polytherapy in the treatment of epilepsy, Neurology, 45 (1995) Suppl 2.Google Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • Joseph Bruni
    • 1
  1. 1.Wellesley Central Site Jones BuildingSt. Michael’s HospitalOntarioCanada

Personalised recommendations